TRANSFORMED MYCOSIS FUNGOIDES

Clinical trials for TRANSFORMED MYCOSIS FUNGOIDES explained in plain language.

Never miss a new study

Get alerted when new TRANSFORMED MYCOSIS FUNGOIDES trials appear

Sign up with your email to follow new studies for TRANSFORMED MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double attack on devastating skin cancer

Disease control Recruiting now

This study is testing a two-part treatment for a severe, widespread red rash caused by a rare skin cancer called cutaneous T-cell lymphoma (CTCL). It combines a drug (mogamulizumab) that targets cancer cells with a blood treatment (ECP) that aims to boost the immune system. The g…

Matched conditions: TRANSFORMED MYCOSIS FUNGOIDES

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

TRANSFORMED MYCOSIS FUNGOIDES

Get alerted when new TRANSFORMED MYCOSIS FUNGOIDES trials appear

Double attack on devastating skin cancer